Disco Pharmaceuticals raised €36M in seed funding to advance therapies for hard-to-treat tumors, co-led by Ackermans and van Haaren and NRW.Bank.
Amount Raised
€36 Million
Round Type
Seed
Investors
Description
Disco Pharmaceuticals, based in Cologne, raised €36M in seed funding. The round was co-led by Ackermans and van Haaren and NRW.Bank, with participation from existing investors. The funds will advance multiple lead antibody-drug conjugates toward IND-enabling studies. The company also appointed Mark Manfredi, Ph.D., as CEO.
Quick answer
Disco Pharmaceuticals raised €36 Million in a Seed round, dated December 11, 2025. Investors: AbbVie Ventures, Sofinnova Partners, M Ventures, Panakes Partners, Ackermans And Van Haaren and Nrw.Bank. Disco Pharmaceuticals is based in Cologne, North Rhine Westphalia, Germany.
- How much did Disco Pharmaceuticals raise?
- Disco Pharmaceuticals raised €36 Million in a Seed round on December 11, 2025.
- Who invested in Disco Pharmaceuticals?
- AbbVie Ventures, Sofinnova Partners, M Ventures, Panakes Partners, Ackermans And Van Haaren and Nrw.Bank are named as investors in this round.
- What does Disco Pharmaceuticals do?
- DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D.
- Where is Disco Pharmaceuticals based and how big is it?
- Disco Pharmaceuticals is based in Cologne, North Rhine Westphalia, Germany.
- Who are the decision-makers at Disco Pharmaceuticals?
- Fundz holds 1 contact at Disco Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Disco Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Axogen raised $124M (Post-IPO Equity) on January 23, 2026.
- Pi Health raised $8.6M on January 23, 2026.
- Cancilico raised $2.9M (Seed) on January 22, 2026.
- Mendra raised $82M (Series A) on January 22, 2026.
- Corxel Pharmaceuticals raised $287M (Series D) on January 22, 2026.
- Infinitopes raised $15M (Seed) on January 21, 2026.
Who to call at Disco Pharmaceuticals, and when
A new round usually means Disco Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Disco Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Disco Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Disco Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Disco Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Disco Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.